Aislyn Boran

Aislyn Boran is a seasoned professional in the field of translational strategy and precision medicine, currently serving as Senior Director at Daiichi Sankyo, Inc. since December 2022. Prior to this role, Aislyn held various positions at Novartis, including Global Biomarker & Diagnostic Director where responsibilities included leading the design and execution of biomarker and diagnostic strategies. Aislyn's experience extends back to roles such as Precision Medicine Associate Director and Expert Global Trial Manager at Theradex, Project Manager/Principal Clinical Scientist at Mount Sinai School of Medicine, and Research Assistant Professor at Mount Sinai Medical Center. Aislyn's career began with a Post-doctoral Fellowship at Mount Sinai Medical Center after obtaining a PhD in Chemistry from Princeton University, and a BA in Chemistry from Rutgers University.